This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Industry-University Cooperation Foundation Hanyang University. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: Innovations by Kun Ho Chung
Introduction
Kun Ho Chung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to treating cerebrovascular diseases. With a total of 3 patents, his work is paving the way for advancements in medical technology.
Latest Patents
One of his latest patents is a nose-to-brain drug delivery device. This device includes a freeze-dried drug container for storing a freeze-dried drug, a restoring solvent container for thawing the drug, a membrane to prevent mixing, and a compressor that provides the necessary driving force. The membrane is opened by the compressor's force, allowing the thawed drug to be sprayed effectively. Another significant patent is a composition for treating apoplexy through nasal administration. This composition contains a Fas targeting peptide (FTP) and is designed to prevent or treat ischemic cerebrovascular disease by effectively delivering drugs to brain tissue.
Career Highlights
Kun Ho Chung is associated with the Industry-University Cooperation Foundation at Hanyang University. His work in this institution has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
He has worked alongside notable colleagues such as Sang-Kyung Lee and Irfan Ullah, further enhancing the impact of his inventions.
Conclusion
Kun Ho Chung's innovative contributions to drug delivery systems highlight his role as a leading inventor in the medical field. His patents reflect a commitment to improving treatment options for cerebrovascular diseases, showcasing the potential of his inventions to make a significant impact on healthcare.